Photocrosslinked poly(amidoamine) nanoparticles for central nervous system targeting

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems

Background:

• Poly(amidoamine)s (PAAs) are versatile synthetic polymers with excellent biocompatibility and biodegradability, suitable for biomedical applications.
• Previous PAA nanoparticle formulations via self-assembly suffered from poor structural stability, leading to premature drug release.
• Developing stable and effective nanoparticle carriers is crucial for targeted drug delivery, especially to the central nervous system (CNS).

Purpose of the Study:

• To develop an innovative and stable method for synthesizing poly(amidoamine) nanoparticles (NPs) for CNS targeting.
• To overcome the limitations of structural instability and premature drug release associated with self-assembled PAA NPs.
• To evaluate the potential of UV-induced crosslinked PAA NPs as drug delivery vectors for the CNS.

Main Methods:

• Synthesis of PAA-based NPs via Ultraviolet (UV) light-induced crosslinking of diacrylamide-terminated oligomers.
• Characterization of NP stability, monodispersity, and drug encapsulation efficiency.
• In vitro evaluation of NP biocompatibility and blood-brain barrier (BBB) permeability using cell culture models.

Main Results:

• UV-induced crosslinking successfully produced monodisperse and structurally stable PAA NPs.
• The crosslinked PAA NPs exhibited improved stability and controlled drug release properties compared to self-assembled NPs.
• PAA NPs demonstrated biocompatibility and high permeability across an in vitro BBB model, successfully encapsulating a model protein.

Conclusions:

• UV-induced crosslinking offers a versatile, environmentally friendly, and efficient method for creating stable PAA NPs.
• These novel PAA NPs show significant potential as effective drug delivery vectors for targeting the central nervous system.
• The developed PAA NPs overcome key challenges in nanoparticle-based CNS drug delivery, paving the way for future therapeutic applications.